Fluperlapine in tardive dyskinesia and p
β
SΓΈren Korsgaard; Ulla Noring; Jes Gerlach
π
Article
π
1984
π
Springer
π
English
β 463 KB
Fluperlapine, a new clozapine-like neuroleptic drug with weak affinity for dopamine receptors, was evaluated in a blind, placebo controlled trial in 11 patients with stable hyperkinesia (ten with tardive dyskinesia (TD) and one with spontaneous dyskinesia). Drug effects during active treatment (200-